Literature DB >> 8398897

Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells.

M S Tsao1, H Zhu, A Giaid, J Viallet, T Nakamura, M Park.   

Abstract

Hepatocyte growth factor (HGF) or scatter factor (SF) has been considered primarily as an endocrine/paracrine factor. We report here that HGF/SF mRNA was expressed by cultured human normal bronchial epithelial cells and many non-small cell lung carcinoma cell lines. Scatter activity was detected in the culture media of these cells, and this activity was inhibited by a neutralizing anti-recombinant human HGF antiserum. Immunostaining confirmed the presence of immunoreactive human HGF-like protein in the cytoplasm of these cultured cells, and in ciliated columnar epithelium of normal human bronchus/bronchioles. The met/HGF/SF receptor of these cultured cells was constitutively phosphorylated on tyrosine residues. A neutralizing anti-recombinant human HGF antiserum decreased the phosphorylation of the receptor, inhibited the proliferation of 45% of the non-small cell lung carcinoma cell lines studied, and stimulated the proliferation of normal bronchial epithelial cells. Altogether, the data demonstrate that HGF/SF and/or HGF-like protein is an autocrine factor for normal and neoplastic human bronchial epithelial cells in culture.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398897

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  40 in total

1.  Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

Authors:  S Yi; M S Tsao
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

2.  The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells.

Authors:  S Koochekpour; M Jeffers; P H Wang; C Gong; G A Taylor; L M Roessler; R Stearman; J R Vasselli; W G Stetler-Stevenson; W G Kaelin; W M Linehan; R D Klausner; J R Gnarra; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Autocrine hepatocyte growth factor provides a local mechanism for promoting axonal growth.

Authors:  X M Yang; J G Toma; S X Bamji; D J Belliveau; J Kohn; M Park; F D Miller
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

4.  Detection and therapeutic implications of c-Met mutations in small cell lung cancer and neuroendocrine tumors.

Authors:  J Voortman; T Harada; R P Chang; J K Killian; M Suuriniemi; W I Smith; P S Meltzer; M Lucchi; Y Wang; G Giaccone
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 5.  Prognostic and predictive value of MET deregulation in non-small cell lung cancer.

Authors:  Giovanna Finocchiaro; Luca Toschi; Letizia Gianoncelli; Marina Baretti; Armando Santoro
Journal:  Ann Transl Med       Date:  2015-04

6.  Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44.

Authors:  D M Kamikura; H Khoury; C Maroun; M A Naujokas; M Park
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.

Authors:  Roya Navab; Jiang Liu; Isolde Seiden-Long; Warren Shih; Ming Li; Bizhan Bandarchi; Yan Chen; Davina Lau; Yen-Fen Zu; Dave Cescon; Chang Qi Zhu; Shawna Organ; Emin Ibrahimov; Dina Ohanessian; Ming-Sound Tsao
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

8.  Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice.

Authors:  Xiao-Ping Chen; Xin-Ping Ren; Jian-Yun Lan; You-Guo Chen; Zong-Ji Shen
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

9.  Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation.

Authors:  S Rong; S Segal; M Anver; J H Resau; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R.

Authors:  Koh-Ichi Nakashiro; Shingo Hara; Yuji Shinohara; Miho Oyasu; Hitoshi Kawamata; Satoru Shintani; Hiroyuki Hamakawa; Ryoichi Oyasu
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.